Percutaneous balloon aortic valvuloplasty
AbstractBackground: As the population ages there is an increasing number of elderly patients with severe symptomatic aortic stenosis and numerous co-morbidities. Decision for aortic valve replacement–a gold standard for the treatment of aortic stenosis–might be dii - cult in this group of patients,in whom open heart procedure may be associated with an unacceptably high risk. Less invasive percutaneous methods are being developed as alternative options for improving the quality of life and prolonging survival. Balloon aortic valvuloplasty is a percutaneous catheterbased method for dilation of the aortic valve, which was in the past almost abandoned due to a high incidence of restenosis and the lack of impact on long-term survival. Twenty years at er its introduction in the elderly patients, together with the development of percutaneous aortic valve implantation methods, balloon aortic valvuloplasty is regaining its role. Case report: We report a case of a 88-yearold woman with severe symptomatic aortic stenosis and a high perioperative risk, who was considered unsuitable for surgical aortic valve replacement. Owing to worsening of her symptoms, she had balloon aortic valvuloplasty performed. At er the procedure she improved clinically and objectively. Conclusions: Our case points out that there are additional therapeutic options for highrisk patients with severe aortic stenosis. Many share the opinion that balloon aortic valvuloplasty will play an important role as a palliative therapy or a bridge to surgical or percutaneous prosthetic valve implantation
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.